Press Releases

Celebrates History of Innovation in Concussion Management Technology Development ImPACT Applications, developer of ImPACT® (Immediate Post-Concussion Assessment and Cognitive Test), ImPACT Pediatric®, and ImPACT Passport™, announced today that more than 12 million of its ImPACT baseline and post-injury neurocognitive tests have been administered since the release of the test in 2006. In the past year…

Worldwide Leader in Neurocognitive Testing to Help UK Youth and Professional Football Clubs Set Higher Player Safety Standards Pittsburgh, Pa. and London, UK – December 6, 2016 – ImPACT Applications, Inc., developer of ImPACT®, ImPACT Pediatric®, and ImPACT Passport™, proudly announces new partnerships with the UK-based football (soccer) governing body The Football Association (The FA) and the International…

Worldwide Leader in Computerized Neurocognitive Testing Offers Training and Educational Resources for the use of ImPACT Applications’ Products in Concussion Management ImPACT Applications, Inc., developer of FDA-cleared ImPACT® and ImPACT Pediatric®, announced today it is approved by the American Psychological Association to sponsor continuing education for psychologists. ImPACT Applications, Inc. maintains responsibility for this program…

A Worldwide Leader in Neurocognitive Testing Offers Funding to Accelerate Knowledge/Improve Care: Concussion Research Program ImPACT Applications, Inc., developer of FDA-approved ImPACT®, FDA-approved ImPACT Pediatric®, and ImPACT Passport, announced today it will donate $600,000 over the next three years to the Accelerate Knowledge/Improve Care: Concussion Research Program established by the Spaulding Rehabilitation Hospital and Harvard…

FDA–Cleared ImPACT Pediatric® Sets Standard for Cognitive Skills Testing for Children Ages 5-11 ImPACT Applications announces ImPACT Pediatric, its newest innovation in the field of concussion management. The first and only FDA-approved concussion-specific tool designed for individuals ages 5-11, ImPACT Pediatric provides healthcare professionals with objective measures of neurocognitive functioning for evaluation and management of…

ImPACT, the most widely-used and most scientifically-validated computerized neurocognitive concussion management tool available, is the first medical device of its kind to receive U.S. Food and Drug Administration (FDA) de novo clearance. FDA clearance has been granted under Computerized Cognitive Assessment Aid for Concussion, a new category for a device that uses an individual’s score(s) on a…

ImPACT Applications, Inc., developer of ImPACT®, ImPACT Passport, and the ImPACT Concussion Management Model™, proudly announces a new partnership with the Dave Duerson Athletic Safety Fund, Inc. (DDASF) to provide underserved schools across the United States with critical components of concussion management: baseline and post-injury testing. During the 2016-2017 academic year, DDASF plans to offer…

Pittsburgh, Pa. and San Francisco – May 26, 2016 – ImPACT Applications, Inc., developer of ImPACT®, ImPACT Passport, and the ImPACT Concussion Management Model™, helped support Dignity Health’s Concussion Education initiative as a sponsor of the organization’s inaugural Dignity Health Foundation Humankindness Gala on May 19, 2016 at San Francisco City Hall. “We are so pleased to have ImPACT…

ImPACT Applications, Inc., developer of the ImPACT® test and ImPACT Concussion Management Model, today announced a partnership with New York Schools Insurance Reciprocal (NYSIR), provider of property and casualty insurance programs for New York State public schools and Boards of Cooperative Educational Services (BOCES), to introduce a comprehensive Head Injury Prevention Program. The Head Injury…

ImPACT Applications, Inc., developer of the ImPACT® test and ImPACT Concussion Management Model, is proud to announce that Mercy Sports Medicine, a division of Mercy, will administer ImPACT baseline and post-injury testing at 100 Ohio and Michigan locations. In addition, Athletic Trainers at Mercy Sports Medicine will receive specialized training in ImPACT neurocognitive baseline and post-injury…